A Phase II trial of docetaxel and carboplatin administered every two weeks as preoperative therapy for stage II or III breast cancer: NCCTG Study N0338
- Citation:
- Am J Clin Oncol vol 36 (6)
- Year:
- 2013
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Pharmas:
- Grants:
- N01 CA035431, U10 CA035269, CA-37404, CA-35431, U10 CA037404, CA-25224, P30 CA015083, U10 CA035431, CA-35269, U10 CA025224
- Corr. Author:
- Authors:
- Vivek Roy Barbara A. Pockaj Jacob B. Allred Heidi Apsey Donald W. Northfelt Daniel Nikcevich Bassam Mattar Edith A. Perez
- Networks:
- Study
- NCCTG-N0338
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- neoadjuvant, breast cancer, dose-dense, docetaxel, carboplatin